fda compounding semaglutide enforcement news november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Compound versions of GLP-1 drugs

However, many of these findings come from preclinical studies, with human evidence still developing

Table Effects of Thiazolidinediones (pioglitazone/rosiglitazone) on Cardiovascular Risk Factors LDL cholesterol particle size Lipoprotein a HDL cholesterol /-- LDL/HDL ratio / Triglycerides Fibrinogen Platelet aggregation Hemodynamic and vascular parameters Intravascular volume Blood pressure Intima-media thickness Endothelial function Urine albumin excretion C-reactive protein Adiponectin Tumor necrosis factor- In a meta-analysis by Nissen and Wolski,[166] published literature and clinical trial registries were searched for cardiovascular end points such as MI and death from cardiovascular causes

Form Health executives say patients lose an average of 15% of their body weight at twelve months

Intended Use & Applications Commonly used in: General laboratory and technical project environments Structured workflow and process support Controlled testing and evaluation setups Educational demonstrations and internal reviews System observation and project-based analysis It is suitable for professional and educational contexts that require well-organized project materials

Our advice is to speak to your GP about the risks and benefits of GLP-1 medicines before taking them, and only take those prescribed by a healthcare professional. The authors say that further studies evaluating the impact of these medications on pregnancy and unborn babies are warranted

Jonathan EC